The only active global HIV vaccine trial, PrEPVacc, has been halted in Africa. Despite the disappointment, this provides critical insights for future research. The quest for an effective HIV vaccine continues! #HIVVaccine#MedicalResearchwww.reuters.com/business/hea...
A trial of an experimental HIV vaccine in Uganda, Tanzania and South Africa has been stopped early after preliminary data suggested it would not be effective in preventing infection, according to the ...
Hope for HIV vaccine falters as Africa-led project ends vaccine trial. 'Last roll of the dice' falls short. 76crimes.com/2023/12/06/h...#HIV#AIDS#HIVvaccine#LGBT#LGBTQ#LGBTrights#LGBTQrights#Uganda#SouthAfrica#Zimbabwe#HIVprevention#vaccine @HelpEndHIV
In quest for HIV vaccine, 'last roll of the dice' falls short; AIDS experts urge renewed effort.
“#African-led and coordinated out of Entebbe, Uganda, with international support, its success could mark the start of a new phase of vaccine development.” #HIVvaccine #HIV edition.cnn.com/2023/08/28/h...
Coordinated out of Uganda, the first-of-its-kind study is taking a double-pronged attack to HIV. Failure could mean no vaccine until at least the 2030s.